Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Lishan Aklog, M.D.$38.4M
Market Cap • 17/04/20242018
(há 6 anos)
2021
(3 years ago)
NASDAQ
Listagem
New York
Sede • New York74
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
LUCDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.